1. Home
  2. FMBH vs NVAX Comparison

FMBH vs NVAX Comparison

Compare FMBH & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Mid Bancshares Inc.

FMBH

First Mid Bancshares Inc.

HOLD

Current Price

$48.83

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.39

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FMBH
NVAX
Founded
1865
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
FMBH
NVAX
Price
$48.83
$8.39
Analyst Decision
Hold
Hold
Analyst Count
5
9
Target Price
$43.40
$11.33
AVG Volume (30 Days)
169.8K
4.2M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
2.33%
N/A
EPS Growth
16.06
309.76
EPS
1.06
N/A
Revenue
N/A
$1,123,479,000.00
Revenue This Year
$9.30
N/A
Revenue Next Year
$6.66
N/A
P/E Ratio
$45.28
N/A
Revenue Growth
N/A
64.69
52 Week Low
$34.51
$6.20
52 Week High
$49.64
$11.85

Technical Indicators

Market Signals
Indicator
FMBH
NVAX
Relative Strength Index (RSI) 62.82 38.42
Support Level $47.02 $7.96
Resistance Level $49.34 $10.10
Average True Range (ATR) 1.10 0.48
MACD -0.09 -0.08
Stochastic Oscillator 73.85 9.16

Price Performance

Historical Comparison
FMBH
NVAX

About FMBH First Mid Bancshares Inc.

First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: